6356-R2 Search Results


recombinant mouse activin riia fc chimera protein, cf  (Bio-Techne corporation)
90
Bio-Techne corporation recombinant mouse activin riia fc chimera protein, cf
Recombinant Mouse Activin Riia Fc Chimera Protein, Cf, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/6356-R2/Recombinant+Mouse+Activin+RIIA+Fc+Chimera+Protein%2C+CF/bio-techne+corporation___6356-r2
Average 90 stars, based on 1 article reviews
recombinant mouse activin riia fc chimera protein, cf - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
recombinant mouse activin riia fc chimera  (R&D Systems)
90
R&D Systems recombinant mouse activin riia fc chimera
Figure 3. Parasitemia development in control, malarial mice treated with PBS and malarial mice treated with rmActivin <t>RIIA</t> Fc chimera. Results were presented as mean ± s.e.m. of N=8. * denotes the significant differences between malaria-infected and control mice, while * * denotes the significant differences between malarial mice treated with PBS and malarial mice treated with rmActivin RIIA Fc chimera via Kruskal-Wallis test followed by Dunn’s post hoc analysis.
Recombinant Mouse Activin Riia Fc Chimera, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/6356-R2/Recombinant+Mouse+Activin+RIIA+Fc+Chimera+Protein%2C+CF/pm33797545-69-1-11
Average 90 stars, based on 1 article reviews
recombinant mouse activin riia fc chimera - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Figure 3. Parasitemia development in control, malarial mice treated with PBS and malarial mice treated with rmActivin RIIA Fc chimera. Results were presented as mean ± s.e.m. of N=8. * denotes the significant differences between malaria-infected and control mice, while * * denotes the significant differences between malarial mice treated with PBS and malarial mice treated with rmActivin RIIA Fc chimera via Kruskal-Wallis test followed by Dunn’s post hoc analysis.

Journal: Tropical biomedicine

Article Title: Inhibition of Activin A suppressed tumor necrosis factor-α secretion and improved histopathological conditions in malarial mice.

doi: 10.47665/tb.38.1.018

Figure Lengend Snippet: Figure 3. Parasitemia development in control, malarial mice treated with PBS and malarial mice treated with rmActivin RIIA Fc chimera. Results were presented as mean ± s.e.m. of N=8. * denotes the significant differences between malaria-infected and control mice, while * * denotes the significant differences between malarial mice treated with PBS and malarial mice treated with rmActivin RIIA Fc chimera via Kruskal-Wallis test followed by Dunn’s post hoc analysis.

Article Snippet: The recombinant mouse activin RIIA Fc chimera (rmActivin RIIA Fc chimera) (R&D Systems, USA) was obtained from myeloma cell line with effective dose (ED50) was typically 6–36ng/mL (R&D Systems, USA).

Techniques: Control, Infection

Figure 4. Concentration of TNF-α, IFN-γ and IL-10 in C+PBS, M+PBS, and M+rmActRIIA Fc chimera mice. Results were expressed in mean ± s.e.m. of N=8. **P<0.005 and ***P<0.0005 significant differences between control and malaria-infected group and malaria-treated group on day 5 of post inoculation using Kruskal-Wallis test followed by Dunn’s post hoc analysis. Keynote: C+PBS = control + phosphate buffer saline; M+PBS = malaria + phosphate buffer saline; M+rmAcrtRIIA Fc Chimera = Malaria + recombinant mouse activin RIIA Fc chimera; abc = control (a) compared to malaria-infected (b) and malaria-treated group (c); ab*** = p<0.0005 significant difference when b compared to a; ac** = p<0.005 significant difference when c compared to a; bc** = p<0.005 significant difference when b compared to c.

Journal: Tropical biomedicine

Article Title: Inhibition of Activin A suppressed tumor necrosis factor-α secretion and improved histopathological conditions in malarial mice.

doi: 10.47665/tb.38.1.018

Figure Lengend Snippet: Figure 4. Concentration of TNF-α, IFN-γ and IL-10 in C+PBS, M+PBS, and M+rmActRIIA Fc chimera mice. Results were expressed in mean ± s.e.m. of N=8. **P<0.005 and ***P<0.0005 significant differences between control and malaria-infected group and malaria-treated group on day 5 of post inoculation using Kruskal-Wallis test followed by Dunn’s post hoc analysis. Keynote: C+PBS = control + phosphate buffer saline; M+PBS = malaria + phosphate buffer saline; M+rmAcrtRIIA Fc Chimera = Malaria + recombinant mouse activin RIIA Fc chimera; abc = control (a) compared to malaria-infected (b) and malaria-treated group (c); ab*** = p<0.0005 significant difference when b compared to a; ac** = p<0.005 significant difference when c compared to a; bc** = p<0.005 significant difference when b compared to c.

Article Snippet: The recombinant mouse activin RIIA Fc chimera (rmActivin RIIA Fc chimera) (R&D Systems, USA) was obtained from myeloma cell line with effective dose (ED50) was typically 6–36ng/mL (R&D Systems, USA).

Techniques: Concentration Assay, Control, Infection, Saline, Recombinant